US

Richard Clinton Kanner

This inventor holds 0 USPTO granted patents, plus 1 CIPO patent.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Richard Clinton Kanner. Retrieved from https://idiyas.com/inventor/richard-clinton-kanner

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...

Title: Richard Clinton Kanner: Innovator in Heavy Metal Removal Technology

Introduction

Richard Clinton Kanner is an inventor based in the United States, known for his work in developing innovative solutions for the removal of heavy metals from medications. His notable invention, the Thimerosal Removal Device, addresses a significant health concern related to heavy metal contamination in pharmaceuticals.

Latest Patents

Richard Clinton Kanner currently holds 0 patents. However, his invention, the Thimerosal Removal Device, showcases his commitment to advancing medical technology. This device is designed to effectively remove heavy metals and heavy metal complexes, such as thimerosal, from medications. The device comprises a dosing mechanism or a solid support that incorporates at least one substantially purified metallothionein protein, which plays a crucial role in the removal process.

Career Highlights

Kanner is associated with MGP Biotechnologies, LLC, where he contributes his expertise in biotechnology and innovation. His work focuses on developing methods to enhance the safety and efficacy of medications by eliminating harmful substances.

Collaborations

Richard Clinton Kanner collaborates with Roger A. Acey, leveraging their combined knowledge and skills to further their research and development efforts in the field of biotechnology.

Conclusion

Richard Clinton Kanner is a dedicated inventor whose work in heavy metal removal technology has the potential to significantly impact the pharmaceutical industry. His innovative approach to addressing contamination issues highlights the importance of safety in medication development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…